Skip to content

Identification of Corticomedullary Differentiation Along Different Stage of Pregnancy

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02193516
Enrollment
330
Registered
2014-07-17
Start date
2014-07-31
Completion date
2015-06-30
Last updated
2014-07-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Nephropathy

Brief summary

Corticomedullary differentiation (CMD) abnormality (absent/reversed) is a parameter that can indicate possible nephropathy. The evolution of CMD across gestation had not been well established. Devrendt et al demonstrated the presence of CMD in all fetuses older then 20 weeks. In our study we would like to determine the exact timing of it's sonographic visualisation. This is a prospective study recruiting women between 14-24 week gestation during routine ultrasound screening. A midsagittal image of each kidney will be taken by a single sonographer and examined for the presence of the CMD by two other sonographers blinded to gestational age.

Interventions

None listed

Sponsors

Meir Medical Center
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 45 Years
Healthy volunteers
Yes

Inclusion criteria

* pregnant women 14-24 weeks * singleton pregnancy * Appropriate for gestational age fetuses * well dated pregnancy

Exclusion criteria

* family history of renal disease * small /large for gestational age fetuses * known structural anomalies * unknown dating

Design outcomes

Primary

MeasureTime frame
CMD presenceA single exam for each participent. The photos will be reviewed within up to 6 month from examination date

Countries

Israel

Contacts

Primary ContactEfrat Hadi, MD
09-7472871

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026